PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Clinical trial NCT05662540 · RECRUITING
Trial details
- NCT number
- NCT05662540
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2025-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.